Tags: ARKK, ARKK Fund, ATTR Amyloidosis, Baker Bros, Biotech, Biotech Investing, Biotech Investments, Biotech Partnerships, Biotech Stocks, Biotechnology, Biotechnology Innovation, Cathie Wood, Cathie Wood Stocks, CRISPR, CRISPR Gene Editing, Fun biotech, Funanc1al, Funanc1al Contrarian Plays, Funanc1al Insider Series, Funanc1al Stocks to Watch, FUNanc1alEdge, funanc1alstocks, gene editing, HAE, High Risk High Reward, Intellia, Intellia Therapeutics, investing humor, NTLA, Phase 3 biotech, Regeneron, Stocks & Fun